Velan Capital Investment Management LP 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 4:17 pm Sale | 2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Velan Capital Investment Management LP | 750,000 3.100% | -500,000 (-40.00%) | Filing |
| 2024-03-28 4:16 pm Purchase | 2024-03-18 | 13G | Outlook Therapeutics, Inc. OTLK | Velan Capital Investment Management LP | 1,250,000 5.600% | 1,250,000 (New Position) | Filing |